SYLBINDA
associated with 6075 other trademarks
Human pharmaceuticals for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervo...

Words that describe this trademark:

autoimmune inflammatory diseases  cardiovascular diseases  prevention treatment  human pharmaceuticals  viral diseases  diseases autoimmune  inflammatory diseases  pharmaceuticals  treatment  diseases 

Serial Number:

86156047

Mark:

SYLBINDA

Status:

Abandoned-No Statement of Use filed

Status Date:

08-07-2017

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Human pharmaceuticals for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

05-06-2014

Mark Drawing Status:

Standart Character Mark

Abandon Date:

08-07-2017

Business Name:

JOHNSON & JOHNSON

Correspondent Name:

Recent Trademark filings by this company